Translations:Dipeptidyl peptidase-4 inhibitor/6/ja: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
Created page with "==事例== {{Anchor|Examples}} このクラスに属する薬物は以下の通りである： * シタグリプチン (FDAは2006年に承認、Merck & Co.がJanuvia/jaとして販売している） * ビルダグリプチン（2007年EU承認、EUではNovartisがGalvusとして販売している) * サキサグリプチン（2009年FDA承認、オングリザとして販売されている） * Linaglipti..."
 
(No difference)

Latest revision as of 19:37, 12 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Dipeptidyl peptidase-4 inhibitor)
==Examples==
Drugs belonging to this class are:
* [[Sitagliptin]] (FDA approved 2006, marketed by [[Merck & Co.]] as [[Januvia]])
* [[Vildagliptin]] (EU approved 2007, marketed in the EU by [[Novartis]] as Galvus)
* [[Saxagliptin]] (FDA approved in 2009, marketed as [[Onglyza]])
* [[Linagliptin]] (FDA approved in 2011, marketed as Tradjenta by [[Eli Lilly and Company]] and [[Boehringer Ingelheim]])
* [[Gemigliptin]] (approved in Korea in 2012, marketed by [[LG Chem|LG Life Sciences]]) Marketed as Zemiglo
* [[Anagliptin]] (approved in Japan as Suiny in 2012, marketed by Sanwa Kagaku Kenkyusho Co., Ltd. and [[Kowa (company)|Kowa Company, Ltd.]])
* [[Teneligliptin]] (approved in Japan as Tenelia in 2012)
* [[Alogliptin]] (FDA approved 2013 as Nesina/ Vipidia, marketed by [[Takeda Pharmaceutical Company]])
* [[Trelagliptin]] (approved for use in Japan as Zafatek/ Wedica in 2015)
* [[Omarigliptin]] (MK-3102) (approved as Marizev in Japan in 2015, developed by [[Merck & Co.]]; research showed that omarigliptin can be used as once-weekly treatment and generally well tolerated throughout the base and extension studies)
* [[Evogliptin]] (approved as Suganon/ Evodine for use in South Korea)
* [[Gosogliptin]] (approved as Saterex for use in Russia)
* [[Dutogliptin]] (PHX- 1149 free base, being developed by [[Phenomix Corporation]]), Phase III
* [[Retagliptin]] (SP-2086), approved in China.
*[[Denagliptin]]
* [[Cofrogliptin]] (HSK- 7653, compound 2)
* [[Fotagliptin]]
* [[Prusogliptin]]

事例

このクラスに属する薬物は以下の通りである：

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Dipeptidyl_peptidase-4_inhibitor/6/ja&oldid=128256"